Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care practitioners, and providers at all levels. is
Guideline should not be considered exclusive of other methods of care reasonably directed at
obtaining the same results. e ultimate judgment concerning the propriety of any course of
conduct must be made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distributor of this clinical reference tool.
Abbreviations
AMD, age-related macular degeneration; AREDS, Age-Related Eye Disease Study;
CNV, choroidal neovascularization; ICG, indocyanine green; IMT, Implantable
Miniature Telescope
™
; MPS, Macular Photocoagulation Study; OCT, optical coherence
tomography; PDT, photodynamic therapy; PRN, individualized discontinuous treatment
regimen; RPE, retinal pigment epithelium; SD-OCT, spectral domain optical coherence
tomography; TAP, Treatment of Age-Related Macular Degeneration with Photodynamic
erapy; VEGF, vascular endothelial growth factor; VIP, Verteporfin in Photodynamic
erapy
Source
American Academy of Ophthalmolog y Retina/Vitreous Panel. Preferred Practice Pattern
®
Guidelines. Age-Related Macular Degeneration. San Francisco, CA: American Academy
of Ophthalmolog y; 2015. Available at: www.aao.org/ppp.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2015 All rights reserved
AAOMAC15073c
